The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders
American Journal of Obstetrics and Gynecology
Zoe E SchaedelMartin C Powell
The study was undertaken to evaluate the levonorgestrel-releasing intrauterine system (LNG-IUS) in managing menorrhagia associated with hemostatic disorders. Retrospective notes review. Nineteen of 28 (68%) patients experienced improvement with the LNG-IUS. There was nonacceptance by 9 of 28 (32%) who refused the LNG-IUS or had it definitively removed. The LNG-IUS should be considered when managing menorrhagia because surgery carries additional risks in this subset of patients.
Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.